CELLFORCURE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

CELLFORCURE Trademark

Serial Number: 79106607 • Registration: 4255776

CELLFORCURE is a trademark filed by Laboratoire Francais Du Fractionnement et des Biotechnologies, on October 12, 2011. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Laboratoire Francais Du Fractionnement et des Biotechnologies, (38 trademarks)

3, avenue des Tropiques
91958 Courtaboeuf , FR

Entity Type: 99

CELLFORCURE

3 avenue des Tropiques

Entity Type: 99

Trademark Details

Filing Date

October 12, 2011

Registration Date

December 11, 2012

Published for Opposition

September 25, 2012

Cancellation Date

June 23, 2023

Goods & Services

Cryopreservation, for autologous or allogenic therapy purposes, of human tissues and their by-products and preparations for cell therapy; custom manufacturing for others, namely, manufacturing of pharmaceutical [ and veterinary ] preparations for health care, for the treatment of humans [ and animals ] suffering from diseases treated by cell therapy or regenerative medicine products, particularly medicines for human purposes including medicines for experimental purposes, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies

Pharmaceutical [ and veterinary ] preparations for the treatment of humans [ and animals ] suffering from diseases treated by cell therapy or regenerative medicine products [ ; sanitary preparations for medical purposes; medical plasters; material for dental fillings and dental impressions; all purpose disinfectants ]

[ Financial and real estate affairs in every type of financial, real estate or securities-related operation and in all commercial or industrial firms in the field of health, namely, financial consultancy, financial analysis, capital accumulation and investment, real estate appraisal; real estate brokerage, namely, real estate acquisition services for business assets; real estate brokerage, namely, rental of commercial property; real estate brokerage, namely, leasing and management for others of commercial property; rental, leasing and management of real estate, particularly of all commercial properties in the nature of facilities, businesses, factories and workshops in the health sector ]

[ Retail store services featuring tissues and their by-products and preparations for cell therapy for autologous or allogenic therapy purposes; marketing services; importing and exporting agencies for health products, particularly of medicines for human purposes including medicines for experimental purposes, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies ]

[ Legal services, namely, advice and assistance for public laboratories and companies, particularly those in the medical and health sectors, on state and federal regulatory compliance requirements; legal services, namely, licensing of patented or non-patented goods, procedures and inventions in the field of health ]

[ Advice and assistance, namely, ] providing information in the field of cell therapy and regenerative medicine for public laboratories and companies, particularly those in the medical and health sectors

Research and development, for autologous or allogenic therapy purposes, for tissues and their by-products and preparations for cell therapy; research and development of health preparations, particularly of medicines for human purposes including medicines for experimental purposes, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies; scientific studies relating to the health sector in the field of cell therapy and regenerative medicine

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 20, 2024 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Apr 1, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 2, 2024 INTS
INVALIDATION PROCESSED
Mar 2, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 23, 2024 INTR
CANCELLED SECTION 71
Jun 23, 2023 C71T
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 26, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 26, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 26, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 26, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 26, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 26, 2022 COAR
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Dec 11, 2021 REM4
INTERNATIONAL REGISTRATION RENEWED
Nov 5, 2021 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Sep 24, 2021 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Jun 12, 2020 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
May 7, 2020 INPS
INVALIDATION PROCESSED
May 7, 2020 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 13, 2020 INPR
CHANGE OF OWNER RECEIVED FROM IB
Dec 27, 2019 CHLD
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jun 13, 2019 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Jun 13, 2019 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 13, 2019 APRE
TEAS SECTION 71 & 15 RECEIVED
Jun 10, 2019 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 11, 2017 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Mar 27, 2015 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jul 21, 2014 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 16, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 15, 2013 FICS
FINAL DISPOSITION PROCESSED
Mar 15, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 11, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 11, 2012 R.PR
NOTIFICATION PROCESSED BY IB
Oct 16, 2012 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 25, 2012 NPUB
PUBLISHED FOR OPPOSITION
Sep 25, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 5, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 5, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 5, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 23, 2012 PREV
ASSIGNED TO LIE
Aug 22, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 14, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 14, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 14, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 14, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 14, 2012 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2012 TROA
REFUSAL PROCESSED BY IB
Mar 6, 2012 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 10, 2012 RFCS
REFUSAL PROCESSED BY MPU
Feb 9, 2012 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 8, 2012 RFCR
NON-FINAL ACTION WRITTEN
Feb 7, 2012 CNRT
ASSIGNED TO EXAMINER
Jan 31, 2012 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 3, 2012 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 28, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 22, 2011 REPR